Great Diamond Partners, LLC Eli Lilly & CO Transaction History

Great Diamond Partners, LLC

$419 Million
Q2 2024

A detailed history of Great Diamond Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Great Diamond Partners, LLC holds 8,487 shares of LLY stock, worth $7.72 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

8,487

Previous 8,552 0.76%

Holding current value

$7.72 Million

Previous $6.65 Million 15.48%

% of portfolio

1.83%

Previous 1.55%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $47,116 - $59,087	-65 Reduced 0.76%	8,487 $7.68 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $850,991 - $1.14 Million	-1,437 Reduced 14.39%	8,552 $6.65 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $151,779 - $178,928	-289 Reduced 2.81%	9,989 $5.82 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $19,996 - $27,567	46 Added 0.45%	10,278 $5.52 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $4,910 - $6,565	-14 Reduced 0.14%	10,232 $4.8 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $283,605 - $333,080	913 Added 9.78%	10,246 $3.52 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $18,328 - $21,356	57 Added 0.61%	9,333 $3.41 Million
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $55,441 - $63,181	-187 Reduced 1.98%	9,276 $3 Million
Q2 2022 Jul 26, 2022	BUY	$278.73 - $327.27 $1.67 Million - $1.96 Million	5,996 Added 172.94%	9,463 $3.07 Million
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $24,173 - $30,040	-103 Reduced 2.89%	3,467 $992,000
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $23,834 - $29,578	106 Added 3.06%	3,570 $986,000
Q3 2021 Oct 21, 2021	BUY	$221.6 - $272.71 $5,983 - $7,363	27 Added 0.79%	3,464 $800,000
Q2 2021 Jul 26, 2021	BUY	$180.55 - $233.54 $16,971 - $21,952	94 Added 2.81%	3,437 $788,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $107,958 - $139,757	-657 Reduced 16.43%	3,343 $624,000
Q4 2020 Jan 26, 2021	SELL	$130.46 - $172.63 $43,704 - $57,831	-335 Reduced 7.73%	4,000 $675,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $5,995 - $6,934	41 Added 0.95%	4,335 $641,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $459,114 - $568,654	4,294 New	4,294 $564,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.

Account

Great Diamond Partners, LLC Eli Lilly & CO Transaction History